SciClone Pharmaceuticals Reaches New 52-Week High at $6.70 (SCLN)
SciClone Pharmaceuticals (NASDAQ:SCLN)’s share price hit a new 52-week high on Monday , StockRatingsNetwork reports. The stock traded as high as $6.70 and last traded at $6.66, with a volume of 385,866 shares trading hands. The stock had previously closed at $6.34.
The stock’s 50-day moving average is $5.2 and its 200-day moving average is $4.93. The company has a market cap of $352.4 million and a P/E ratio of 15.10.
SciClone Pharmaceuticals (NASDAQ:SCLN) last released its earnings data on Monday, August 11th. The company reported $0.20 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.10 by $0.10. The company had revenue of $32.50 million for the quarter, compared to the consensus estimate of $33.40 million. During the same quarter last year, the company posted ($0.04) earnings per share. SciClone Pharmaceuticals’s revenue was up 10.9% compared to the same quarter last year. On average, analysts predict that SciClone Pharmaceuticals will post $0.49 earnings per share for the current fiscal year.
In other SciClone Pharmaceuticals news, Director Nancy T. Chang acquired 25,040 shares of the stock on the open market in a transaction dated Friday, August 15th. The shares were purchased at an average cost of $6.00 per share, with a total value of $150,240.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) is a specialty pharmaceutical company.
Receive News & Ratings for SciClone Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciClone Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.